SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1991 |
Sector | Life Science |
Employees | 2,524 |
Revenue | 3.7B USD (2023) |
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. Incyte was founded in 1991 and is based in Wilmington, Delaware.
DEAL STATS | # |
---|---|
Overall | 4 of 5 |
Sector (Life Science) | 3 of 4 |
Type (Add-on Acquisition) | 3 of 4 |
State (North Carolina) | 1 of 1 |
Country (United States) | 4 of 5 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-05-09 |
Ariad Pharmaceuticals - Iclusig Business
Cambridge, Massachusetts, United States Ariad Pharmaceuticals - Iclusig Business is a kinase inhibitor. Iclusig is BCR-ABL, an abnormal tyrosine kinase that is expressed in chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL). |
Buy | $140M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-04-23 |
Escient Pharmaceuticals
San Diego, California, United States Escient Pharmaceuticals is a clinical-stage company that develops novel therapeutics to address various neurosensory-inflammatory disorders. The company’s pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for treating various mast cell-mediated disorders and MRGPRX4 for cholestatic pruritus. Escient Pharmaceuticals is based in San Diego, California. |
Buy | - |